ZUPREVO® now available in the Middle East for treatment, prevention of bovine respiratory disease
ZUPREVO (tildipirosin) — a novel macrolide antibiotic offering an excellent combination of speed, duration of activity and convenience — is now available in Jordan and Lebanon for managing bovine respiratory disease (BRD) in beef cattle, including veal calves.
Specifically, the product is indicated for the treatment and prevention of BRD associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, the three most prevalent bacterial pathogens in the BRD complex.
BRD is one of the most common and costly disease affecting beef cattle, taking a substantial toll annually on both animal health, productivity and welfare. Effective BRD treatment and prevention is, therefore, critical to protecting cattle and keeping beef operations sustainable.
ZUPREVO gives you both options and puts you in control.
MSD Animal Health recently announced the launch of BRAVECTO™ (fluralaner), a new chewable tablet for dogs that provides extended control against fleas and ticks for up to 12 weeks in a single dose.
Fleas and ticks can introduce a host of problems for a dog and its family. Flea- and tick-borne diseases can transmit an array of health conditions including skin disease, anemia and Lyme Disease in dogs and humans alike.
BRAVECTO represents a powerful new weapon in the fight for flea and tick control in dogs. Fleas and ticks pose a significant threat to dog health and many pet owners forget to re-apply their flea and tick protection every month, adding to the threat of infestation and parasite-borne diseases that could harm their pet.
The active substance of BRAVECTO, fluralaner, is a new ectoparasiticide that works systemically to kill fleas and ticks within hours and continues protecting the dog for up to 12 weeks . In fact, while other treatments may take up to 48 hours to be effective, BRAVECTO starts eliminating fleas as early as 2 hours, with 88% efficacy within 4 hours. In a 2013 study, flea control efficacy remained at 99.9% after 12 weeks and tick control efficacy remained at 100% at 12 weeks. BRAVECTO is safe for puppies over eight weeks old, as well as pregnant and lactating females.
MSD Animal Health Middle East has launched a next-generation ear infection treatment for canines that combines the benefits of three different agents.
Posatex Otic Suspension is a seven-day treatment for sufferers of severe otitis externa available in 7.5mg, 15mg and 30g specifications and functions by combating the yeast and bacteria infections that cause the disease.
It contains the active ingredients orbifloxacin, mometasone furoate monohydrate and posaconazole, offering a combination of antifungal, antibiotic and anti-inflammation benefits.
Enramycin, the active ingredient of ENRADIN®, is a polypeptide antibiotic with strong action against Gram positive bacteria, including Clostridium perfringens, an important cause of enteritis and performance loss in poultry. This large polypeptide molecule is not absorbed by the intestinal tract. Added to poultry feed, ENRADIN® helps to improve weight gain and feed efficiency.* Enradin’s superior activity for Clostridium perfringens and its consistent efficacy make it the leading brand and most effective feed medication for Clostridial Enteritis.